4D Molecular Therapeutics... (FDMT)
4.16
-0.37 (-8.17%)
At close: Mar 03, 2025, 3:59 PM
4.13
-0.48%
After-hours: Mar 03, 2025, 03:59 PM EST
4D Molecular Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 149.34M | 249.11M | 218.64M | 315.43M | 276.73M | 49.65M | 91.76M | 23.85M |
| Short-Term Investments | 275.54M | 39.12M | 161.2M | 94.78M | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 10.95M | 4.91M | 67.65M | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 84.84M | 684K | 1.08M | -58.55M | 602K | 677K | 429K | 105K |
| Receivables | n/a | n/a | n/a | 47K | 1.49M | 978K | 1.12M | 321K |
| Inventory | n/a | n/a | -5.79M | -8.5M | n/a | n/a | n/a | 1.00 |
| Other Current Assets | 10.05M | 8.36M | 6.96M | 8.46M | 8.89M | 1.88M | 783K | 328K |
| Total Current Assets | 434.93M | 296.59M | 220.51M | 315.43M | 282.66M | 52.51M | 94.07M | 24.5M |
| Property-Plant & Equipment | 40.61M | 31.66M | 35.35M | 28.95M | 5.07M | 5.05M | 2.47M | 2.72M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 125.45M | 43.3M | 41.34M | 38.06M | 5.67M | 5.73M | 2.9M | 2.82M |
| Total Assets | 560.38M | 339.89M | 261.85M | 353.49M | 288.33M | 58.23M | 96.97M | 27.32M |
| Account Payables | 4.39M | 3.52M | 3.32M | 4.76M | 1.79M | 1.74M | 954K | 460K |
| Deferred Revenue | 257K | 273K | 884K | 2.6M | 6.59M | 5.86M | 4.91M | 4.38M |
| Short-Term Debt | 5.64M | 3.15M | 5.31M | 2.46M | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 18.87M | 12.01M | 6.74M | 9.03M | 8.37M | 5.35M | 2.1M | 1.01M |
| Total Current Liabilities | 29.15M | 18.95M | 15.73M | 16.34M | 16.74M | 12.96M | 8.05M | 5.91M |
| Long-Term Debt | 18.97M | 11.52M | 13.47M | 15.22M | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 1.66M | 617K | 233K | 334K | 1.97M | 104.65M | 103.43M | 18.81M |
| Total Long-Term Liabilities | 20.63M | 13.11M | 14.78M | 18.04M | 15.2M | 118.25M | 116.5M | 41M |
| Total Liabilities | 49.78M | 32.06M | 30.51M | 560.48M | 31.94M | 131.2M | 124.56M | 46.91M |
| Total Debt | 24.61M | 14.67M | 16.12M | 16.45M | n/a | n/a | n/a | n/a |
| Common Stock | 5K | 4K | 3K | 3K | 3K | 1K | 1K | 1K |
| Retained Earnings | -576.2M | -415.33M | -314.49M | -207M | -135.68M | -79.03M | -30.03M | -20.48M |
| Comprehensive Income | n/a | 16K | -1.2M | -423K | -288.33M | -102.98M | -102.98M | -18.51M |
| Shareholders Equity | 510.61M | 307.83M | -314.49M | -207M | 256.39M | -72.97M | -27.59M | -19.59M |
| Total Investments | 275.54M | 50.08M | 166.11M | 162.43M | n/a | n/a | n/a | n/a |